[Patient safety in clinical intervention research]

Area of Science:

• Clinical research methodology
• Patient safety monitoring
• Data and Safety Monitoring Committees (DSMC)

Context:

• Clinical intervention research necessitates rigorous patient safety monitoring.
• A 2009 symposium highlighted the roles of various stakeholders in ensuring research integrity.
• Ethical approval by an accredited Ethics Committee is a prerequisite for initiating clinical research.

Purpose:

• To outline the essential components of patient safety monitoring in clinical trials.
• To define the responsibilities of investigators, sponsors, and Data and Safety Monitoring Committees (DSMCs).
• To emphasize the importance of interim decision-making protocols and safety reporting.

Summary:

• Patient safety is primarily the responsibility of investigators and sponsors post-Ethics Committee approval.
• Data and Safety Monitoring Committees (DSMCs) are increasingly appointed to evaluate interim data and advise sponsors.
• Decisions to prematurely end a trial should be clinical decisions, not solely based on statistical thresholds, with a primary focus on safety.

Impact:

• Ensures robust patient protection throughout clinical intervention studies.
• Promotes standardized and ethical practices in clinical trial management.
• Facilitates informed decision-making regarding trial continuation or termination based on comprehensive safety assessments.